Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Catalyst Pharmaceuticals (CPRX) Return on Capital Employed (2016 - 2025)

Catalyst Pharmaceuticals' Return on Capital Employed history spans 15 years, with the latest figure at 0.06% for Q4 2025.

  • For Q4 2025, Return on Capital Employed fell 22.0% year-over-year to 0.06%; the TTM value through Dec 2025 reached 0.06%, down 22.0%, while the annual FY2025 figure was 0.07%, 29.0% down from the prior year.
  • Return on Capital Employed reached 0.06% in Q4 2025 per CPRX's latest filing, down from 0.29% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.37% in Q2 2023 to a low of 0.06% in Q4 2025.
  • Average Return on Capital Employed over 5 years is 0.26%, with a median of 0.27% recorded in 2022.
  • Peak YoY movement for Return on Capital Employed: dropped -22bps in 2021, then increased 15bps in 2025.
  • A 5-year view of Return on Capital Employed shows it stood at 0.26% in 2021, then skyrocketed by 33bps to 0.34% in 2022, then crashed by -31bps to 0.24% in 2023, then grew by 19bps to 0.28% in 2024, then tumbled by -77bps to 0.06% in 2025.
  • Per Business Quant, the three most recent readings for CPRX's Return on Capital Employed are 0.06% (Q4 2025), 0.29% (Q3 2025), and 0.29% (Q2 2025).